chartexchange

Sionna Therapeutics to Participate in Upcoming November 2026 Investor Conferences

GlobeNewswire Inc. | Nov 2, 2026 8:00 AM EST

WALTHAM, Mass., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to develop novel medicines for cystic fibrosis (CF), today announced that management will participate in fireside chats at the following upcoming investor events:

Read original article